Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelica Calleri

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Cancer Biology & Therapy|August 3, 2010
Angiogenic cells, macroparticles and RNA transcripts in laparoscopic vs open surgery for colorectal cancerAnna Bono, Paolo Bianchi, Andrea Locatelli, et al.
British Journal of Haematology|October 9, 2003
Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphomaGiovanni Martinelli, Daniele Laszlo, Francesco Bertolini, et al.
Blood|March 18, 2006
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapyPatrizia Mancuso, Marco Colleoni, Angelica Calleri, et al.
Plos One|December 16, 2014
A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patientsPatrizia Mancuso, Angelica Calleri, Giuliana Gregato, et al.
F1000Research|January 8, 2019
Dissecting diffuse large B-cell lymphomas of the "not otherwise specified" type: the impact of molecular techniquesStefano A Pileri, Enrico Derenzini, Federica Melle, et al.
International Journal of Cancer|September 9, 2014
The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cellsStefania Orecchioni, Francesca Reggiani, Giovanna Talarico, et al.
Human Pathology|May 25, 2019
Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomasValentina Tabanelli, Chiara Corsini, Stefano Fiori, et al.
Endothelium : Journal of Endothelial Cell Research|June 24, 2008
Circulating endothelial cell number and viability are reduced by exposure to high altitudePatrizia Mancuso, Fedro Peccatori, Andrea Rocca, et al.
American Journal of Hematology|October 4, 2016
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?Francesco Zaja, Valentina Tabanelli, Claudio Agostinelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus BevacizumabAngelica Calleri, Anna Bono, Vincenzo Bagnardi, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cancer Biology & Therapy|August 3, 2010
Angiogenic cells, macroparticles and RNA transcripts in laparoscopic vs open surgery for colorectal cancerAnna Bono, Paolo Bianchi, Andrea Locatelli, et al.
British Journal of Haematology|October 9, 2003
Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphomaGiovanni Martinelli, Daniele Laszlo, Francesco Bertolini, et al.
Blood|March 18, 2006
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapyPatrizia Mancuso, Marco Colleoni, Angelica Calleri, et al.
Plos One|December 16, 2014
A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patientsPatrizia Mancuso, Angelica Calleri, Giuliana Gregato, et al.
F1000Research|January 8, 2019
Dissecting diffuse large B-cell lymphomas of the "not otherwise specified" type: the impact of molecular techniquesStefano A Pileri, Enrico Derenzini, Federica Melle, et al.
International Journal of Cancer|September 9, 2014
The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cellsStefania Orecchioni, Francesca Reggiani, Giovanna Talarico, et al.
Human Pathology|May 25, 2019
Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomasValentina Tabanelli, Chiara Corsini, Stefano Fiori, et al.
Endothelium : Journal of Endothelial Cell Research|June 24, 2008
Circulating endothelial cell number and viability are reduced by exposure to high altitudePatrizia Mancuso, Fedro Peccatori, Andrea Rocca, et al.
American Journal of Hematology|October 4, 2016
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?Francesco Zaja, Valentina Tabanelli, Claudio Agostinelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus BevacizumabAngelica Calleri, Anna Bono, Vincenzo Bagnardi, et al.
Pageof 5